HighTower Advisors
ALT icon

HighTower Advisors’s Altimmune ALT Stock Holding History

HighTower Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,909
Closed -$18.5K – 3659
2025
Q3 		$18.5K Buy
4,909
+2,456
+100% +$9.48K ﹤0.01% 3679
2025
Q2 		$9.49K Sell
2,453
-2,797
-53% -$15.1K ﹤0.01% 3651
2025
Q1 		$26.3K Buy
5,250
+2,592
+98% +$16.4K ﹤0.01% 3501
2024
Q4 		$19.2K Sell
2,658
-3,118
-54% -$23.8K ﹤0.01% 3546
2024
Q3 		$34K Sell
5,776
-88
-2% -$596 ﹤0.01% 3457
2024
Q2 		$39K Buy
+5,864
New +$43.3K ﹤0.01% 3331

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

HighTower Advisors's ALT Position: Q4 2025 in Review

HighTower Advisors sold out of Altimmune (ALT) in Q4 2025, closing a stake of 4,909 shares — an estimated $18.5K sold.

HighTower Advisors first reported a position in ALT in Q2 2024 and held it in 6 quarters. The position peaked at $39K in Q2 2024. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • HighTower Advisors reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • HighTower Advisors sold 4,909 Altimmune shares in Q4 2025, an estimated $18.5K.
  • HighTower Advisors first reported a position in Altimmune in Q2 2024 and held it in 6 quarters.
  • HighTower Advisors's Altimmune position peaked at $39K in Q2 2024.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on HighTower Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.